Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th March, 2021 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2021 are communicated to the Stock Exchanges. Alkem Laboratories Ltd - 539523 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
This is to inform you that shareholders of the Company, through Postal Ballot process, have approved the special resolution for the amendments to Memorandum of Association (MOA) of the Company on 24th March, 2021. Pursuant to Regulation 30 read with Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the brief details of the amendments made to the MOA of the Company is appended below. The MOA of the Company has been amended to align it as per the provisions of Table A of the Schedule I of the Companies Act, 2013 by carrying out the necessary changes. Kindly take a note of the same. Alkem Laboratories Ltd - 539523 - Details Of The Voting Results Of The Postal Ballot Through Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In continuation of our letter dated 22nd February, 2021 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolution as proposed in the Postal Ballot Notice dated 05th February, 2021 has been passed by the members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website viz. https://www.alkemlabs.com/. The approval is deemed to have been received on the last date of remote e-voting, i.e. 24th March, 2021. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to intimate you that Alkem Laboratories Limited has agreed to partner with Tata Memorial Centre to establish an advanced Radiotherapy Facility as a part of the Homi Bhabha Cancer Hospital and Research Center, Muzaffarpur and also establish 3 mini cancer units in the following cities of Bihar namely Buxar, Jehanabad and Bhagalpur as part of its CSR activity. A press release in this regard is enclosed herewith. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to intimate you that Alkem Laboratories Limited (the 'Company') has launched Brivaracetam in India under the brand name 'Brivasure', an affordable anti-epileptic drug for the treatment of Epilepsy in India. Brivasure has received authorization from the Drug Controller General of India (DCGI). A press release in this regard is enclosed herewith. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 read alongwith Schedule Ill of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"}, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Lakshadweep (Marathi) regarding Postal Ballot Notice and E-Voting information. The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In furtherance to our intimation dated 05.02.2021, this is to inform you that pursuant to the provisions of Sec 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Company is in the process of conducting postal ballot (only by means of remote e-voting) for seeking approval of members of the Company for business as specified in the Postal Ballot Notice dated 05.02.2021. In terms of Reg 30 of SEBI (LODR) Reg, 2015, please find enclosed the Postal Ballot Notice dated 05.02.2021 The remote e-voting period commences on Tuesday, 23.02.2021 at 9.00 am and shall remain open for a period of 30 days i.e. till Wednesday, 24.03. 2021 at 5.00 pm. CS Manish L. Ghia, Partner, M/s Manish Ghia & Associates, Company Secretaries, Mumbai has been appointed as Scrutinizer for conducting Postal Ballot process in fair and transparent manner. Kindly take note of the same.
Buy Alkem Laboraties; target of Rs 3430: Motilal Oswal
Motilal Oswal is bullish on Alkem Laboraties has recommended buy rating on the stock with a target price of Rs 3430 in its research report dated February 06, 2021.
Buy Alkem Laboratories; target of Rs 3242: Dolat Capital Market
Dolat Capital Market is bullish on Alkem Laboratories has recommended buy rating on the stock with a target price of Rs 3242 in its research report dated February 07, 2021.